Mechanisms of Antibiotic Resistance in Pathogenic Bacteria: A Comprehensive Review

Antonino Nocera^*
*Correspondence: Antonino Nocera, Department of Medical Microbiology, University of Ghana Medical School, Korle Bu, Accra P.O. Box KB 4236, Ghana, Email:

Keywords

Antibiotic resistance • Pathogenic bacteria • Enzymatic degradation • Target modification • Efflux pumps

Introduction

Antibiotic resistance has emerged as one of the most pressing issues in modern medicine, leading to increased morbidity, mortality, and healthcare costs. The ability of pathogenic bacteria to evade the effects of antibiotics compromises the treatment of infectious diseases, necessitating a deeper understanding of the underlying mechanisms. This review aims to provide a comprehensive overview of the various strategies employed by bacteria to resist antibiotic action, highlighting the importance of ongoing research and innovation in combating this global health threat [1,2].

Literature Review

Antibiotic resistance in pathogenic bacteria is facilitated through various mechanisms that can be broadly categorized into enzymatic degradation, target modification, efflux pumps, biofilm formation, and genetic factors. Enzymatic degradation involves the production of enzymes such as beta-lactamases and carbapenemases that hydrolyze the antibiotic's active components, rendering them ineffective. Aminoglycoside-modifying enzymes also contribute by chemically altering aminoglycosides to prevent their binding to bacterial targets [3]. Target modification encompasses changes in bacterial proteins that antibiotics typically bind to, such as alterations in penicillin-binding proteins (PBPs) in methicillin-resistant Staphylococcus aureus (MRSA) and ribosomal protection proteins that prevent antibiotics like tetracyclines from inhibiting protein synthesis. Efflux pumps are transport proteins that actively expel a variety of antibiotics from the bacterial cell, reducing their intracellular concentration and efficacy. Biofilm formation provides a protective environment where bacteria can evade antibiotics and the host immune response [4]. Within biofilms, bacteria can enter a dormant state that reduces their susceptibility to antibiotics targeting actively growing cells. The genetic basis of resistance includes horizontal gene transfer mechanisms—such as conjugation, transformation, and transduction—that spread resistance genes among bacterial populations. Additionally, spontaneous mutations can lead to resistance, with selective pressure from antibiotic use driving the proliferation of resistant strains. Understanding these mechanisms is crucial for developing new therapeutic strategies and informing antibiotic usage policies [5].

Discussion

The mechanisms of antibiotic resistance in pathogenic bacteria are multifaceted and complex, involving both intrinsic and acquired factors. The interplay between these mechanisms exacerbates the challenge of treating bacterial infections. Understanding these pathways is crucial for the development of new antibiotics and alternative therapeutic strategies, such as bacteriophage therapy and immune modulation. Moreover, addressing antibiotic resistance requires a coordinated approach, including stringent antibiotic stewardship, infection control measures, and robust surveillance systems [6].

Conclusion

Antibiotic resistance in pathogenic bacteria is a dynamic and evolving threat to global health. This review has elucidated the key mechanisms by which bacteria resist antibiotic action, underscoring the necessity for continued research and innovation. Effective countermeasures must encompass novel drug development, enhanced diagnostic tools, and comprehensive public health policies. By integrating these efforts, we can mitigate the impact of antibiotic resistance and safeguard the efficacy of existing and future antimicrobial agents.

Acknowledgement

None.

Conflict of Interest

None.

References

1. Chiò, Adriano, G. Logroscino, B. J. Traynor and J. Collins, et al. "Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature." Neuroepidemiology 41 (2013): 118-130.

   Google Scholar, Crossref, Indexed at

2. Ryman, Sephira, Andrei A. Vakhtin, Sarah Pirio Richardson and Henry C. Lin. "Microbiome–gut–brain dysfunction in prodromal and symptomatic Lewy body diseases." J Neurol 270 (2023): 746-758.

   Google Scholar, Crossref, Indexed at

3. Parra-Cantu, Carolina, Arnulfo Zaldivar-Ruenes, Manuel Martinez-Vazquez and Hector R. Martinez. "Prevalence of gastrointestinal symptoms, severity of dysphagia, and their correlation with severity of amyotrophic lateral sclerosis in a Mexican cohort." Neurodegener Dis 21 (2021): 42-47.

   Google Scholar, Crossref, Indexed at

4. Samara, Verena C., Patricia Jerant, Summer Gibson and Mark Bromberg. "Bowel, bladder, and sudomotor symptoms in ALS patients." J Neurol Sci 427 (2021): 117543.

   Google Scholar, Crossref, Indexed at

5. Wright, Michelle L., Christina Fournier, Madelyn C. Houser and Malú Tansey, et al. "Potential role of the gut microbiome in ALS: a systematic review." Biol Res Nurs 20 (2018): 513-521.

   Google Scholar, Crossref, Indexed at

6. Salvatore, Silvia, Alice Folegatti, Cristina Ferrigno and Licia Pensabene, et al. "To diet or not to diet this is the question in Food-Protein-Induced Allergic Proctocolitis (FPIAP)—A comprehensive review of current recommendations." Nutrients 16 (2024): 589.

   Google Scholar, Crossref, Indexed at